Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03904199 · ClinicalTrials.gov registry record · Early Phase 1
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
A Early Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT03904199 is a Early Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 9 participants.
The verdict
NCT03904199, a Early Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the outcomes between hospitalized cancer patients with high blood sugar receiving the current standard of care of administering insulin, and hospitalized cancer patients receiving a new, individualized method of insulin administration.
Interventions
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2021-11-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03904199
The ClinicalTrials.gov registry entry for NCT03904199 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT03904199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03904199 about?
NCT03904199 is a clinical study titled "Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia". The purpose of this study is to compare the outcomes between hospitalized cancer patients with high blood sugar receiving the current standard of care of administering insulin, and hospitalized cancer patients receiving a new, individualized method of insulin administration.
What is the current status of trial NCT03904199?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2019-04-04. Estimated completion is 2021-11-02.
What interventions are being tested in trial NCT03904199?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT03904199?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.